Croda International PLC (CRDA)

Industry Specialty Chemicals


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

3,385.00p

Buy

3,388.00p

arrow-up31.00p (+0.92%)

Prices updated at 31 Dec 2024, 12:35 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Croda International PLC is engaged in manufacturing specialty chemical. It supplies specialty ingredients for the personal care industry, pharmaceutical and nutritional markets. It also sells coating and polymer, and adhesives.

Income statement

20222023
2,089m1,695m
986m730m
445m248m
21.2814.61
649m171m
926m388m
Sales, General and administrative541m483m
Interest expenses26m26m
Provision for income taxes127m64m
Operating expenses541m483m
Income before taxes780m236m
Net income available to common shareholders649m171m
4.6581.225
Net interest income-21m-11m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)4.6481.223
Free cash flow per share1.0391.4042
Book value/share16.891116.5631
Debt equity ratio0.1991220.280425

Balance sheet

20222023
Current assets1,160m909m
Current liabilities488m320m
Total capital2,817m2,941m
Total debt616m710m
Total equity2,416m2,353m
Total non current liabilities--
Loans402m588m
Total assets3,612m3,579m
Total liabilities--
Cash and cash equivalents321m173m
Common stock140m140m

Cash flow

20222023
Cash at beginning of period94m282m
Cash dividends paid-144m-151m
156m149m
Investments (gains) losses425m-410m
282m150m
Net income--
308m338m
-152m-189m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.